GDERF — Galderma Group AG/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2021390 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 13,393,000,000 | 780,000,000 | 5,244,000,000 |
| Jun 2025 | — | — | — | — | 12,877,000,000 | 458,000,000 | 5,147,000,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$6,347,000,000
Inventory
$525,000,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,922,999,808
EBITDA
$1,386,000,000
Free Cash Flow
$874,625,024
Enterprise Value
$44,755,783,680
Total Cash
$839,000,000
Total Debt
$2,716,000,000
Shares Out
233,188,937
Trailing EPS
$3.64
Book Value
$35.23
ROE
10.8%
ROA
5.4%
Div Yield
0.24%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,241,000,000 | 876,000,000 | 613,000,000 | 13,393,000,000 | 5,244,000,000 | 8,150,000,000 | 1,185,000,000 |
| Dec 2024 | 4,440,000,000 | 678,000,000 | 231,000,000 | 12,617,000,000 | 4,827,000,000 | 7,790,000,000 | 488,000,000 |
| Dec 2023 | 4,117,000,000 | 611,000,000 | -57,000,000 | 12,471,000,000 | 7,102,000,000 | 5,369,000,000 | 165,000,000 |
| Dec 2022 | 3,823,900,000 | 406,000,000 | -98,500,000 | — | — | — | 111,300,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC. | $254.47B | $686.79 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $218.41B | $231.09 | — |
| KLAC | KLA CORP | $188.36B | $144.56 | — |
| DHR | DANAHER CORP /DE/ | $158.71B | $225.77 | — |
| LMT | LOCKHEED MARTIN CORP | $136.37B | $590.34 | — |
News headlines (Yahoo Finance, 1h cache)
Mexico Becomes the First Market Worldwide to Receive Approval for Galderma’s Restylane® Shaype™ for Both Chin and Its First Jawline Indication
2026-11-13 06:00 · Yahoo
Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition
2026-11-02 17:00 · Yahoo
Galderma (SWX:GALD) Stock Could Be 39% Undervalued Following China Approval
2026-10-23 16:07 · Yahoo
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines
2026-10-23 05:00 · Yahoo
Galderma raises 2026 sales growth outlook after Q3 revenue beats forecasts
2026-10-22 06:43 · Yahoo
Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance
2026-10-22 05:00 · Yahoo
AMWC Dubai 2026: Galderma Reinforces Its Injectable Aesthetics Leadership
2026-10-21 05:00 · Yahoo
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis
2026-10-15 05:00 · Yahoo
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
2026-10-14 05:00 · Yahoo
Galderma to buy Blackstone-owned ZO Skin Health for $1.5 bln
2026-10-14 00:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.